Search Results - "Ko, A H"

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer by Ko, A H, Tempero, M A, Shan, Y-S, Su, W-C, Lin, Y-L, Dito, E, Ong, A, Wang, Y-W, Yeh, C G, Chen, L-T

“…Background: PEP02, also known as MM-398, is a novel nanoliposomal irinotecan that has improved pharmacokinetics and tumour bio-distribution of the free drug…”
Get full text

Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates by Kelley, R.K., Nimeiri, H.S., Munster, P.N., Vergo, M.T., Huang, Y., Li, C.-M., Hwang, J., Mulcahy, M.F., Yeh, B.M., Kuhn, P., Luttgen, M.S., Grabowsky, J.A., Stucky-Marshall, L., Korn, W.M., Ko, A.H., Bergsland, E.K., Benson, A.B., Venook, A.P.

“…Based upon preclinical evidence for improved antitumor activity in combination, this phase I study investigated the maximum-tolerated dose (MTD), safety,…”
Get full text

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer by Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K

“…Background: This phase 1 clinical trial was conducted to determine the safety, maximum-tolerated dose (MTD), and pharmacokinetics of imatinib, bevacizumab, and…”
Get full text

Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE) by Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Askoxylakis, V., Ko, A.H.

“…Preclinical data suggest that dual blockade of the insulin-like growth factor-1 receptor (IGF-1R) and HER3 pathways has superior activity to IGF-1R blockade…”
Get full text

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer by KO, A. H, HWANG, J, VENOOK, A. P, ABBRUZZESE, J. L, BERGSLAND, E. K, TEMPERO, M. A

“…The use of serial serum measurements of the carbohydrate antigen 19-9 (CA19-9) to guide treatment decisions and serve as a surrogate end point in clinical…”
Get full text

Cavitary Pulmonary Lesions in Patients Infected with Human Immunodeficiency Virus by Gallant, Joel E., Ko, Andrew H.

“…The differential diagnosis of cavitary pulmonary lesions in individuals infected with human immunodeficiency virus (HIV) is broad, especially in patients with…”
Get full text

CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer by Ko, A.H., Cubillo, A., Kundranda, M., Zafar, S.F., Meiri, E., Bendell, J., Alguel, H., Rivera Herrero, F., Ahn, E., Watkins, D., Pelzer, U., Charu, V., Downing, W., Wang, B., Kuesters, G., Pipas, J.M., Santillana, S.L., Askoxylakis, V.

Get full text

A phase I trial of the combination of temsirolimus (TEM) and sorafenib (SOR) in advanced hepatocellular carcinoma (HCC) by Kelley, R. K., Nimeiri, H. S., Vergo, M. T., Bergsland, E. K., Ko, A. H., Munster, P. N., Reinert, A., Mulcahy, M. F., Benson, A. B., Venook, A. P.

“…Abstract only…”
Get full text

Hedgehog signaling in gastrointestinal development and disease by Harmon, E B, Ko, A H, Kim, S K

“…The development of the gastrointestinal (GI) tract and its associated parenchymal organs depends on Hedgehog signals from the endoderm to the surrounding…”
Get more information

Non-Hodgkin's lymphoma and Kaposi's sarcoma causing cavitary lung lesions in a patient with AIDS: an HIV-associated collision tumor by Ko, A H, Thomas, D L, Gallant, J E

Get more information

Kinetic characterization of a prestart cell division control step in yeast. Implications for the mechanism of alpha-factor-induced division arrest by Ko, H A, Moore, S A

“…In Saccharomyces cerevisiae yeast, a cycloheximide-sensitive “prestart” step (Ki = 0.12 +/- 0.05 microM) is passaged greater than or equal to 4 to less than or…”
Get full text

LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer by Ko, A H, Cubillo, A, Kundranda, M, Zafar, S F, Meiri, E, Bendell, J, Alguel, H, Rivera Herrero, F, Ahn, E, Watkins, D, Pelzer, U, Charu, V, Downing, W, Wang, B, Kuesters, G, Pipas, J M, Santillana, S L, Askoxylakis, V

Get full text

Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’: Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79–87 by Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Askoxylakis, V., Ko, A.H.

Get full text

Clinical Outcomes Associated with very Late Relapses in Diffuse Large Cell Lymphoma by Ko, Andrew H., Yuen, Alan R.

“…While the majority of patients achieve complete remission (CR) following treatment for diffuse intermediate-grade and immunoblastic non-Hodgkin's lymphoma,…”
Get full text

Community level exposure to chemicals and oxidative stress in adult population by Hong, Yun-Chul, Park, Eun-Young, Park, Min-Seon, Ko, Jeong Ah, Oh, Se-Young, Kim, Ho, Lee, Kwan-Hee, Leem, Jong-Han, Ha, Eun-Hee

“…Little information is available on the role of environmental chemical exposure in oxidative stress. This study was designed to investigate whether exposure to…”
Get full text

Green tea consumption and risk of stomach cancer: A meta‐analysis of epidemiologic studies by Myung, Seung Kwon, Bae, Woo Kyung, Oh, Seung Min, Kim, Yeol, Ju, Woong, Sung, Joohon, Lee, Yeon Ji, Ko, Jeong Ah, Song, Jong Im, Choi, Hyuck Jae

“…This meta‐analysis investigated the quantitative association between the consumption of green tea and the risk of stomach cancer in epidemiologic studies using…”
Get full text

Acinetobacter species isolates from a range of environments: species survey and observations of antimicrobial resistance by Choi, Ji-Young, Kim, Yejin, Ko, Eun Ah, Park, Young Kyoung, Jheong, Weon-Hwa, Ko, GwangPyo, Ko, Kwan Soo

“…Abstract Acinetobacter species isolates from a range of environments, including soil, were investigated. We determined 16S rRNA and rpoB gene sequences for…”
Get full text

Repression, denial, backlash: sexually transmitted diseases in the People's Republic of China by Ko, A H

Get more information

Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan by Ko, Andrew H

“…Nanoliposomal irinotecan (nal-IRI) was originally developed using an efficient and high-loading capacity system to encapsulate irinotecan within a liposomal…”
Get full text

Acinetobacter sp. isolates from emergency departments in two hospitals of South Korea by CHOI, Ji-Young, EUN AH KO, KI TAE KWON, SHINWON LEE, CHOEL IN KANG, CHUNG, Doo-Ryeon, KYONG RAN PECK, SONG, Jae-Hoon, KWAN SOO KO

“…A total of 114 Acinetobacter sp. isolates were collected from patients in the emergency departments (EDs) of two Korean hospitals. Most isolates belonged to…”
Get full text